TrialFrontiers in immunology2025

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.

Tessa Hattenhauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.